These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30897704)

  • 1. Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands.
    Balaguer FA; Mühlethaler T; Estévez-Gallego J; Calvo E; Giménez-Abián JF; Risinger AL; Sorensen EJ; Vanderwal CD; Altmann KH; Mooberry SL; Steinmetz MO; Oliva MÁ; Prota AE; Díaz JF
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclostreptin and microtubules: is a low-affinity binding site required?
    Prussia AJ; Yang Y; Geballe MT; Snyder JP
    Chembiochem; 2010 Jan; 11(1):101-9. PubMed ID: 19946930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
    Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
    Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of a cyclostreptin analogue with the microtubule taxoid site: the covalent reaction rapidly follows binding.
    Bai R; Vanderwal CD; Díaz JF; Hamel E
    J Nat Prod; 2008 Mar; 71(3):370-4. PubMed ID: 18298077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
    Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
    Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.
    Field JJ; Pera B; Calvo E; Canales A; Zurwerra D; Trigili C; Rodríguez-Salarichs J; Matesanz R; Kanakkanthara A; Wakefield SJ; Singh AJ; Jiménez-Barbero J; Northcote P; Miller JH; López JA; Hamel E; Barasoain I; Altmann KH; Díaz JF
    Chem Biol; 2012 Jun; 19(6):686-98. PubMed ID: 22726683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.
    Calvo E; Barasoain I; Matesanz R; Pera B; Camafeita E; Pineda O; Hamel E; Vanderwal CD; Andreu JM; López JA; Díaz JF
    Biochemistry; 2012 Jan; 51(1):329-41. PubMed ID: 22148836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
    Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
    Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
    Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P; Lu P; Sharom FJ; Fang WS
    Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions.
    Tang Y; Rodríguez-Salarichs J; Zhao Y; Cai P; Estévez-Gallego J; Balaguer-Pérez F; Redondo Horcajo M; Lucena-Agell D; Barasoain I; Díaz JF; Fang WS
    Eur J Med Chem; 2017 Sep; 137():488-503. PubMed ID: 28624703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.
    Risinger AL; Jackson EM; Polin LA; Helms GL; LeBoeuf DA; Joe PA; Hopper-Borge E; Ludueña RF; Kruh GD; Mooberry SL
    Cancer Res; 2008 Nov; 68(21):8881-8. PubMed ID: 18974132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insight into the stabilization of microtubules by taxanes.
    Prota AE; Lucena-Agell D; Ma Y; Estevez-Gallego J; Li S; Bargsten K; Josa-Prado F; Altmann KH; Gaillard N; Kamimura S; Mühlethaler T; Gago F; Oliva MA; Steinmetz MO; Fang WS; Díaz JF
    Elife; 2023 Mar; 12():. PubMed ID: 36876916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eribulin on microtubule binding and dynamic instability are strengthened in the absence of the βIII tubulin isotype.
    Wilson L; Lopus M; Miller HP; Azarenko O; Riffle S; Smith JA; Jordan MA
    Biochemistry; 2015 Oct; 54(42):6482-9. PubMed ID: 26435331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. βIII-Tubulin: biomarker of taxane resistance or drug target?
    Karki R; Mariani M; Andreoli M; He S; Scambia G; Shahabi S; Ferlini C
    Expert Opin Ther Targets; 2013 Apr; 17(4):461-72. PubMed ID: 23379899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of microtubules by taxane diterpenoids: insight from docking and MD simulations.
    Yadava U; Gupta H; Roychoudhury M
    J Biol Phys; 2015 Mar; 41(2):117-33. PubMed ID: 25542396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site.
    Lo YC; Cormier O; Liu T; Nettles KW; Katzenellenbogen JA; Stearns T; Altman RB
    Nat Commun; 2019 Mar; 10(1):1033. PubMed ID: 30833575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
    Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
    Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites.
    Field JJ; Pera B; Gallego JE; Calvo E; Rodríguez-Salarichs J; Sáez-Calvo G; Zuwerra D; Jordi M; Andreu JM; Prota AE; Ménchon G; Miller JH; Altmann KH; Díaz JF
    J Nat Prod; 2018 Mar; 81(3):494-505. PubMed ID: 29023132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.